{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:15:46Z","timestamp":1764656146360,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00246-021-02585-2","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:02:45Z","timestamp":1618038165000},"page":"1082-1087","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Deciphering Genetic Variants of Warfarin Metabolism in Children With Ventricular Assist Devices"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9428-4934","authenticated-orcid":false,"given":"Anwar","family":"Baban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca G.","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Di Molfetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Cicenia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Agolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Drago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Di Chiara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,10]]},"reference":[{"issue":"3","key":"2585_CR1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1182\/blood-2011-08-372722","volume":"119","author":"TT Biss","year":"2012","unstructured":"Biss TT, Avery PJ, Brandao LR, Chalmers EA, Williams MD, Grainger JD, Leathart JB, Hanley JP, Daly AK, Kamali F (2012) VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. Blood 119(3):868\u2013873","journal-title":"Blood"},{"key":"2585_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1182\/blood-2011-07-365502","volume":"119","author":"C Moreau","year":"2012","unstructured":"Moreau C, Bajolle F, Siguret V, Lasne D, Golmard JL, Elie C, Beaune P, Cheurfi R, Bonnet D, Loriot MA (2012) Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement. Blood 119:861\u2013867","journal-title":"Blood"},{"issue":"26","key":"2585_CR3","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1182\/blood-2010-05-283861","volume":"116","author":"U Nowak-Gottl","year":"2010","unstructured":"Nowak-Gottl U, Dietrich K, Schaffranek D, Eldin NS, Yasui Y, Geisen C, Mitchell LG (2010) In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes. Blood 116(26):6101\u20136105","journal-title":"Blood"},{"key":"2585_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/clpt.2011.186","volume":"90","author":"PJ Avery","year":"2011","unstructured":"Avery PJ, Jorgensen A, Hamberg AK, Wadelius M, Pirmohamed M, Kamali F (2011) EU-PACT Study Group: A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy. Clin Pharmacol Ther 90:701\u2013706","journal-title":"Clin Pharmacol Ther"},{"key":"2585_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.tpj.6500417","volume":"7","author":"M Wadelius","year":"2007","unstructured":"Wadelius M, Pirmohamed M (2007) Pharmacogenetics of warfarin: Current status and future challenges. Pharmacogenomics J 7:99\u2013111","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"2585_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/tpj.2014.31","volume":"14","author":"DB Hawcutt","year":"2014","unstructured":"Hawcutt DB, Ghani AA, Sutton L, Jorgensen A, Zhang E, Murray M, Michael H, Peart I, Smyth RL, Pirmohamed M (2014) Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects. Pharmacogenomics J 14(6):542\u2013548","journal-title":"Pharmacogenomics J"},{"key":"2585_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.4065\/mcp.2009.0278","volume":"84","author":"TP Moyer","year":"2009","unstructured":"Moyer TP, O\u2019 Kane DJ, Baudhuin LM (2009) Warfarin sensitivity genotyping: A review of the literature and summary of patient experience. Mayo Clin Proc 84:1079\u20131094","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"2585_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00246-005-1150-x","volume":"27","author":"K Kosaki","year":"2006","unstructured":"Kosaki K, Yamaghishi C, Sato R, Semejima H, Fuijita H, Tamura K, Maeyama K, Yamagishi H, Sugaya A, Dodo H, Tanigawara Y, Takahashi T (2006) 1173C>T polymorphism in VKORC1 modulates the required warfarin dose. Pediatr Cardiol 27(6):685\u2013688","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"2585_CR9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.thromres.2015.09.018","volume":"136","author":"J Zhang","year":"2015","unstructured":"Zhang J, Tian L, Zhang Y, Shen J (2015) The influence of VKORC1 gene polymorphism on warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysis. Thrombosis Res 136(5):955\u2013961","journal-title":"Thrombosis Res"},{"issue":"8","key":"2585_CR10","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1182\/blood-2007-11-122010","volume":"111","author":"MD Caldwell","year":"2008","unstructured":"Caldwell MD, Awad T, Johnson JA (2008) CYP4F genetic variant alters required warfarin dose. Blood 111(8):4106\u20134112","journal-title":"Blood"},{"issue":"6","key":"2585_CR11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1124\/mol.109.054833","volume":"75","author":"MG McDonald","year":"2009","unstructured":"McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE (2009) CYP4F2 is a vitamin K1 oxidase An explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol 75(6):1337\u20131346","journal-title":"Mol Pharmacol"},{"issue":"2","key":"2585_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2217\/14622416.10.2.261","volume":"10","author":"P Borgiani","year":"2009","unstructured":"Borgiani P, Ciccacci C, Forte V, Sirianni E, Novelli L, Bramanti P, Novelli G (2009) CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population. Pharmacogenomics 10(2):261\u2013266","journal-title":"Pharmacogenomics"},{"key":"2585_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/FPC.0b013e3283311347","volume":"19","author":"JE Zhang","year":"2009","unstructured":"Zhang JE, Jorgensen AL, Alfirevic A, Williamson PR, Toh CH, Park BK, Pirmohamed M (2009) Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy. Pharmacogenet Genomics 19:781\u2013789","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"2585_CR14","doi-asserted-by":"publisher","first-page":"e27963","DOI":"10.5812\/cardiovascmed.28724v2","volume":"4","author":"A Tabib","year":"2015","unstructured":"Tabib A, Najibi B, Dalili M, Baghaei R, Poopak B (2015) Enzyme polymorphism in warfarin dose management after pediatric cardiac surgery. Res Cardiovasc Med 4(3):e27963","journal-title":"Res Cardiovasc Med"},{"issue":"4","key":"2585_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/MAT.0000000000000231","volume":"61","author":"M Awad","year":"2015","unstructured":"Awad M, Czer LS, Soliman C, Mirocha J, Ruzza A, Pinzas J, Rihbany K, Chang D, Moriguchi J, Ramzy D, Esmailian F, Kobashigawa J, Arabia F (2015) Prevalence of Warfarin Genotype Polymorphisms in Patients with Mechanical Circulatory Support. ASAIO J 61(4):391\u2013396","journal-title":"ASAIO J"},{"key":"2585_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2217\/pgs.10.49","volume":"11","author":"SA Scott","year":"2010","unstructured":"Scott SA, Khasawneh R, Peter I, Korneich R, Desnick RJ (2010) Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups. Pharmacogenomics 11:781\u2013791","journal-title":"Pharmacogenomics"},{"key":"2585_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2217\/14622416.10.2.261","volume":"102","author":"P Borgiani","year":"2009","unstructured":"Borgiani P, Ciccacci C, Forte V, Sirianni E, Novelli L, Placido B, Novelli G (2009) CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population. Pharmacogenomics 102:261\u2013266","journal-title":"Pharmacogenomics"},{"issue":"5","key":"2585_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/MAT.0000000000000390","volume":"62","author":"VK Topkara","year":"2016","unstructured":"Topkara VK, Knotts RJ, Jennings DL, Garan AR, Levin AP, Breskin A, Castagna F, Cagliostro B, Yuzefpolskaya M, Takeda K, Takayama H, Uriel N, Mancini DM, Eisenberger A, Naka Y, Colombo PC, Jorde UP (2016) Effect of CYP2C9 and VKORC1 gene variants on warfarin response in patients with continuous-flow left ventricular assist devices. ASAIO J 62(5):558\u2013564","journal-title":"ASAIO J"},{"key":"2585_CR19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00246-012-0592-1","volume":"34","author":"N Nguyen","year":"2013","unstructured":"Nguyen N, Anley P, Zhang M, Thompson A, Jennings L (2013) Genetic and clinical determinants influencing warfarin dosing in children with heart disease. Pediatr Cardiol 34:984\u2013990","journal-title":"Pediatr Cardiol"},{"issue":"9","key":"2585_CR20","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1182\/blood.V94.9.3007","volume":"94","author":"W Streif","year":"1999","unstructured":"Streif W, Andrew M, Marzinotto V, Massicotte P, Chan AK, Julian JA, Mitchell L (1999) Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 94(9):3007\u20133014","journal-title":"Blood"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-021-02585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-021-02585-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-021-02585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:10:39Z","timestamp":1623330639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-021-02585-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2585"],"URL":"https:\/\/doi.org\/10.1007\/s00246-021-02585-2","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"type":"print","value":"0172-0643"},{"type":"electronic","value":"1432-1971"}],"subject":[],"published":{"date-parts":[[2021,4,10]]},"assertion":[{"value":"30 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all parents or caregivers of patients enrolled in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study received approval from Bambino Ges\u00f9 Children\u2019s Hospital and Research Ethics Committee and was conducted according to the Declaration of Helsinki guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}